Protein crystallization in vivo provides some fascinating examples of biological selfassembly. Here, we provide a selective survey to show the diversity of functions for which protein crystals are used, and the physical properties of the crystals that are exploited. Where known, we emphasize how the nature of the protein-protein interactions leads to control of the crystallization behaviour.
Introduction
The crystallization of proteins in vitro is a subject of immense practical importance, partly because of the vital role played by protein crystallography in modern structural molecular biology. Thus, considerable effort has been devoted to understanding how to crystallize proteins in the laboratory [1] . In the last decade, colloid scientists have contributed significantly to this enterprise [2] . By treating globular proteins in a coarse-grained manner, it turns out that certain regularities, such as the existence of an optimal 'crystallization window', can be rationalised [3] . Initially, the simplest possible model was used -complex protein molecules were reduced to perfect hard spheres with isotropic, short-range inter-particle attraction. Subsequently, more realistic models begin to appear. For example, the 'stickiness' can occur in patches (either regular [4] or random [5] ). On the other hand, the study of proteins can give new insights into problems in colloid science, such as the existence of finite, equilibrium clusters in charged, attractive particle systems [6] . Thus, the intellectual traffic between the study of protein solutions and colloidal suspensions has proved fruitful for both sides.
Protein crystals also occur in vivo. This phenomenon is, of course, one example of biological self-assembly. Some other examples include the formation of viral capsids [7] and multi-protein complexes such as the ribosome [8] . Compared to these more celebrated examples, in vivo protein crystallization has been relatively neglected: we know of only one attempt to provide a general survey (see the last chapter in [1] ). One of the reasons for this relative neglect is that in vivo protein crystallization is perceived to be an atypical behaviour, and for good reason: protein aggregation and crystallization would normally be expected to be deleterious to the cell. Indeed, the difficulty of crystallizing proteins in vitro may reflect precisely the 'negative selection' that has occurred in vivo over evolutionary time scales against easily crystallizable variants [9] .
The purpose of this article is to provide a review of in vivo protein crystallization from the perspective of colloid science. Unlike other articles in this journal, many of the references will necessarily not be 'current' in the chronological sense -some of the first examples of in vivo protein crystals go back nearly a century or more. However, we hope that the topic is of significant current interest. Understanding in vivo protein crystallization, and perhaps how cells have evolved to avoid it in the main, may be an area that is ripe for contributions from colloid scientists. We organise the examples reviewed according to the putative biological functions of the protein crystals in vivo.
In the concluding discussion we seek to draw together some elements of commonality between different kinds of in vivo protein crystals, between in vivo and in vitro protein crystallization, as well as point to some of the interesting differences.
Protein storage
Perhaps the most 'obvious' use for protein crystals in vivo is for storage, either temporarily, with a view to future utilization or excretion, or as a mean of permanent sequestration. This section gathers examples of this kind.
Seeds
It is instructive to start our review with seeds, since the occurrence of in vivo protein crystals here is, at least at first sight, rather 'obvious' from a physical sciences point of view. A major function of a seed is to act as a storage organ, of carbohydrates, and, in some cases, of proteins. Seed proteins were amongst the first to be crystallized in the laboratory [1] . Given the ease of in vitro crystallization, and the fact that many seed proteins are present at very high concentrations, one may expect the presence of protein crystals in vivo. This expectation is amply confirmed by reality: the packing within membrane-bound storage organelles, 'protein bodies' (previously) or protein storage vesicles (in more recent literature), often contain crystalline portions. Indeed, protein crystals in seeds were first reported as early as 1855, and so is one of the first known examples of in vivo crystallization. Perhaps the most striking demonstration of crystallinity comes from diffraction from actual seeds. In particular, dry and wet slices of seeds from rock melon and pumpkin were found to shown powder diffraction rings consistent with a surprisingly simple lattice (face-centred cubic) [10] .
In more detail, the protein storage vesicles in most non-legume seeds consist of three parts: an amorphous matrix, 'crystalloids' embedded in the matrix containing proteins packed in lattice structure, and crystals of the salts of phytic or oxalic acids (see, e.g. [11] , especially the schematic drawing in Figure 1 of this review, and Figures 10 and 11 showing lattice steps in crystalloids). The detailed mechanism whereby such complex storage organelles are constructed is still an active area of research [12, 13] . It is clear that understanding why some of the proteins are sequestered into crystalline compartments (e.g., is it some form of micro-phase separation?) will be a crucial part of this enterprise.
In common with other legumes, soya beans show no evidence of crystalloids. Nevertheless, one of the soya storage proteins provides a surprising example of in vivo crystallinity when expressed in transgenic wheat [14] . Since the domestication of Glycine max in northern China more than 3000 years ago, soya beans have been a major source of dietary protein for a substantial fraction of the world's population. The two main soya storage proteins are glycinin and β-conglycinin (often also referred to by their sedimentation coefficients as 11S and 7S) [15] . Like many other seed proteins, the wild type of both soya proteins are easy to crystallise. Nevertheless, their atomic-resolution structures have remained illusive until recently [16, 17] , because crystals from the wild-type protein do not give diffraction patterns of sufficient quality due to 'multimer heterogeneity'. Here we concentrate on glycinin.
Glycinin is a hexamer, each monomer of which is composed of an acidic and a basic subunit. Each pair is synthesized as a single precursor (but later cleaved). Three of these monomers are first assembled into a trimer in the endoplasmic reticulum. The trimer is transported to the storage vesicle, further proteolytically modified, and then assembled into the final hexamer. The monomer subunits are produced from multiple genes, with between 50-90% sequence identity between them. Mixtures of these monomers assemble to give rise to heterogeneous hexamers, which cannot give high-resolution diffraction patterns. One strategy to overcome this problem is to produce recombinant glycinin in transgenic wheat containing a single type of subunit. In such transgenic wheat, the glycinin is observed to adopt a lattice structure when the seed develops [14] . Thus, it appears that modifications that favour crystalline packing (here, molecular homogeneity) but do not otherwise hinder function do indeed lead to crystallization in vivo.
Secretory granules
Many cell types are involved in regulated secretion, in which particular proteins are synthesised in significant quantities, and then stored in concentrated form ready for release from the cell in response to some external signal. On synthesis proteins destined for secretion enter into the rough endoplasmic reticulum (RER), and then pass through the Golgi apparatus, where proteins are sorted according to their destination. Vesicles with the relevant protein in a condensed state form at the trans-Golgi network, and then further densify to form the mature secretory granules [18] . The proteins in these granules are probably more often in a dense amorphous state, but there are a significant number of examples where they are crystalline. When secretion is triggered, the vesicles migrate to the cell surface, and release their contents by exocytosis. The protein granules then dissolve.
In order for this secretory pathway to be successful, the cell must exert considerable control over the protein's interactions through control of the environment experienced by the protein. Otherwise premature aggregation or crystallization, say in the RER [19] , might occur or the granule might fail to dissolve on exocytosis. As one passes through the RER and Golgi apparatus, the pH decreases and the concentration of divalent ions, such as Ca 2+ and Zn
2+
changes significantly. Indeed, aggregation has been found to occur in vitro for a series of secretory proteins under conditions that mirror those of the transGolgi cisternae [20] . Also, it is fairly common for the secretory protein to be initially synthesised as a proprotein, which is then proteolytically processed in the Golgi apparatus to produce the active form. This provides another avenue to control the protein's aggregation and crystallization properties.
It has also been suggested that the aggregation might play an important role in the sorting of secretory proteins in the Golgi apparatus by a mechanism called "selection by retention" [18, 20] . Lysosomal proteins and those that are part of the constitutive secretory pathway have a sorting signal in their amino acid sequence and are actively trafficked away from the Golgi apparatus to their correct destination. The essence of the proposed mechanism is that what remains ends up in the regulated secretory pathway. It has been suggested that, as well as the absence of a sorting signal, the formation of insoluble aggregates prevents these proteins from entering into vesicles heading to these alternative destinations.
Insulin
One of the most well-known examples of regulated secretion is that of insulin, and one for which there is a good understanding of the structural changes associated with the secretory process [21] . Granules of insulin are secreted from the islets of Langerhans in the pancreas into the blood in response to elevated glucose levels in the blood. The granules are typically 200-300 nm in size, and contain insulin in a crystal form. Insulin and proinsulin exists in a number of oligomeric states, and this is exploited in the secretory process. The initially synthesised proinsulin assembles into a soluble hexamer in the presence of zinc irons. Conversion of proinsulin to insulin by cleavage of the 'C peptide' from the A and B chains occurs during formation of the secretory vesicle. The insulin hexamers are insoluble in the presence of zinc ions and crystallization occurs rapidly.
The function of the crystalline form is not clear, but it may serve to protect the insulin from further proteolytic processing. Interestingly, in species such as the guinea pig, where insulin is not hexameric, dense amorphous aggregates occur instead [21] . In this context, it would be interesting to compare the rate of proteolysis on the differently aggregated forms of insulin in vitro.
On exocytosis of the insulin granules, there is a significant increase in pH and a decrease in concentration of Zn 2+ and Ca 2+ . These changes lead to the deprotonation of six glutamate residues in close proximity at the centre of the hexamer, and the loss of the coordinating zinc ions. The resulting electrostatic repulsion causes the crystals to dissolve rapidly to give the functionally active monomeric form of insulin. Given this context, it is unsurprising that insulin is one of the most rapidly crystallizing proteins in vitro.
White blood cells
Granulocytes are a type of white blood cell characterized by secretory granules packed with potent chemicals that can be released to combat infection. Some of the proteins in these granules are stored in the form of crystals. For example, in the eosinophils depicted in Fig. 1(a) , large rectangular crystals consisting of the eosinophil major basic protein (EMBP) are apparent [22] . This protein is synthesised as pro-EMBP, where the pro-portion of the protein is highly acidic, presumably in order to counteract the highly basic nature of EMBP and thus protect the cell during transport to the granule, where the pro-portion is then removed [23] .
Eosinophils also have smaller granules containing Charcot-Leyden crystal protein [24] . Interestingly, after release of this protein by eosinophils during an inflammatory response, the high concentrations can lead the protein to recrystallize. The resulting hexagonal bipyramidal crystals, known as Charcot-Leyden crystals, are characteristic of eosinophil-associated allergic inflammation, such as asthma, and were first observed in 1851 [25] . Whether this recrystallization serves any functional purpose is not clear, but possibilities are that it provides a way to deactivate excesses of this destructive protein, or that it provides the first step in the removal of the protein from the tissue, e.g. the subsequent uptake of the crystals by macrophages has been observed.
Protists
There are many examples of crystalline secretory granules amongst the protists [26] , a diverse group of mainly single-celled eukaryotic organisms. Usually the material extruded from the cell is for the purpose of predation of or protection against other microorganisms. Two of the most well-studied examples are from Tetrahymena [27] and Paramecium [28] , and illustrate the complexity of crystalline secretory granules that can be formed. The secretory granule of Paramecium, called a trichocyst, (Fig. 1(b) ) involves the assembly of at least three different families of closely related polypeptides, each localized to different regions of the trichocyst to form a structure that is of the order of 3-4 µm in size. These polypeptides are derived by proteolytic cleavage of proproteins during the development of the granule, and the absence of any leads to misassembly of the trichocyst [29] . Furthermore, this proteolysis also serves as a means to control the intermolecular interactions during trafficking, since the soluble proproteins can easily pass through the endoplasmic reticulum and the Golgi apparatus, whereas the final polypeptides are insoluble. Therefore, proteolysis triggers aggregation, and the retention of these polypeptides in the maturing secretory granules. Interestingly, in the absence of this proteolysis, the proproteins end up in the constitutive secretory pathway [28] .
Rapid and synchronized exocytosis in response to external stimulus is triggered by the release of calcium ions leading to substantial (roughly by a factor of 8) expansion of the crystal as it is extruded. This process is irreversible, implying that the original assembly of the trichocyst results in a metastable structure with energy stored in the crystal lattice. The purpose seems to be defensive. The explosive release of the trichocysts can push Paramecium away from a potential predator, giving it a chance to escape [30] . The physical mechanisms causing the expansion is unknown, although it may be relevant that the polypeptides involved are all acidic. Similar large expansions of amorphous polyelectrolyte gels occur in the secretory granules of mast cells, where the negatively-charged polymer matrix exhibits a condensed state in the presence of divalent ions, but undergoes a rapid expansion in the presence of monovalent ions, or an electric field [31] .
Bacterial parasporal crystals
On sporulation, a number of species of bacteria, the most well-studied of which is Bacillus thuringiensis, form protein crystals containing insecticidal toxins (Fig. 1(c) ). When ingested, these crystals dissolve in the alkaline environment of the gut of the insect larvae, releasing the protoxins which are then cleaved to produce the active form that attacks the gut wall and facilitates entry of germinating spores into the insect host. There is a large family of these toxins, and the crystal structures of many of these are known [32, 33] . It is common for these proteins to be cysteine-rich and it is thought that intermolecular disulphide bonds contributes to their crystallization behaviour. In others, there are strong intermolecular salt bridges. Interestingly, when expressed in a variety of other organisms (even plants) crystal formation can still occur [34] . The reason for packaging the toxins in a crystal is probably to provide a concentrated dose of toxin in a form that is insoluble at neutral pH, thus increasing the longevity of the toxins in the environment of the soil [33] .
Encapsulation
Some particularly interesting examples of protein crystallization occur in certain genera of insect viruses, namely cytoplasmic and nuclear polyhedrosis viruses, granulosis viruses and entomopoxviruses [35] . All these viruses coopt the infected cells to express large quantities of proteins (polyhedrin, granulin and spheroidin, respectively, in the above classes) in the late stages of infection. (Indeed, the baculovirus protein expression systems, one of the most popular eukaryotic alternatives to E. coli, make use of the relevant promoter in cut-down versions of the Autographa californica nuclear polyhedrosis virus, where the gene for the expressed protein replaces that for polyhedrin.) These proteins then crystallize around the the virions to provide a protective environment for the viruses after death of the insect larvae, which can remain intact for periods of years in the soil. The viruses also induce cell lysis, aiding release of the crystals from the dead insect larvae, and even induce larvae to climb upwards (hence the name Wipfelkrankheit or tree-top disease) to aid as wide dispersal as possible [36] . On ingestion of the crystals by a new insect larva, the protein crystals dissolve in the alkaline environment of the gut, releasing the virus to infect the new host.
Depending on species, the protein crystals can either encapsulate single or multiple virus particles. The example shown in Fig. 1(d) shows a crystal en-capsulating a single rod-like virus particle. Particularly, interesting is the uniformity of the crystals -the cross-sections of the crystal are almost perfectly circular, and the crystals are relatively monodisperse. These features raise a host of physical questions. How does the crystal nucleate around the virus, in this case on the surface of the membrane surrounding the virus, particularly as heterogeneous nucleation usually leads to crystal growth away from the nucleating particle [37] ? What limits the growth of the crystals to a size that is large enough to offer sufficient protection to the virus, whilst not using excessive amounts of protein? Interestingly, there is some evidence from ultrastructural studies that for granulosis viruses, such as in Fig. 1(d) , the nucleation of the crystal usually begins at one end of the rod virus, and that the crystal then grows around the virus [38] .
The mechanical properties of the crystals are also important for their function. Whereas most protein crystals are very fragile, in order to protect the virus, these crystal are very tough, implying very strong interprotein interactions. However, how then are the proteins transported to the site of crystallization without any premature aggregation or crystallization? Indeed, if crystals of polyhedrin produced in vivo are dissolved in alkali in vitro (having prevented expression of a protease that co-crystallizes with polyhedrin, and whose purpose is to speed up dissolution of the crystal in the alkaline environment of the gut by cleaving polyhedrin into smaller pieces) on lowering the pH aggregation rather than crystallization occurs [39] . Consequently, the crystal structure of these proteins are unknown. It may be that other highly expressed proteins, such as p10 [40] , which forms filaments that are intimately associated with the polyhedrin crystals and is involved in the formation of envelopes around the crystals, may also play a role in the transport of polyhedrin.
Solid-state catalysts: Peroxisome enzymes
Peroxisomes are membrane-bound organelles found in eukaryotic cells that are responsible for a variety of chemical processes, such as the breakdown of lipids and alcohol, that are catalysed by enzymes, such as catalase, urate oxidase and alcohol oxidase, that are typically assembled into regular crystals. These reactions are usually oxidative in nature and often involve unpleasant chemical species such as H 2 O 2 , hence the need for confinement in a specific organelle. The crystals can be both co-crystals of a mixture of enzymes or a pure crystal of one enzyme depending on the cell involved, and typically have an open crystal structure with clearly observable solvent channels.
The peroxisomes in yeast cells fed on methanol provide a particularly wellstudied example [41] . In this case, the crystals are pure alcohol oxidase, and the peroxisomes can take up a majority of the cell volume. Of course, it is im-portant that the enzymes do not assemble or take on their active form prior to entry into the peroxisome. In the case of alcohol oxidase, the active form is an octamer. After synthesis on free ribosomes in the cytosol, alcohol oxidase binds to another protein, pyruvate carboxylase (pyc), preventing formation of the octamer. Only after entry into the peroxisome and release from pyc, which remains in the cytosol, does the protein form the octamer and spontaneously assemble into a crystal. Interestingly, in mutants that lack peroxisomes, crystals do not form, except at particularly high concentrations of alcohol oxidase, when they can form in the cytoplasm [42] .
Why are the enzymes organized into crystals? As the molecules that the enzymes act upon are trafficked to the peroxisome, there is no need for the enzymes to diffuse through solution to find their reactants. Moreover, as the relevant molecules are not other proteins, but are generally relatively small, they can easily diffuse through the open crystals. The only requirement is that the active site is not at a crystal contact. The crystals, therefore, represent nanoporous solid-state catalysts.
Plugging leaks

Woronin bodies
In filamentous fungi, cellular compartments are connected by septal pores that allow trafficking between cells. When a cell is damaged, the septal pore is sealed by Woronin bodies, preventing cytoplasmic bleeding. Each Woronin body is a hexagonal platelet ≈ 5 µm across, and consists of a proteinaceous core that is primarily crystalline HEX-1 surrounded by a membrane [43] . The HEX-1 protein contains a peroxisomal targeting sequence that causes it to be trafficked to the organelles, and thus the Woronin bodies can be classified as peroxisomes, although, unlike most peroxisomes, they are not known to carry out a catalytic function. HEX-1 crystallizes readily in vitro [43] , and its structure has been determined to high resolution [44] .
Interestingly, a mutation exists in HEX-1 that leads to the formation of aberrant spherical Woronin bodies, taken by the investigators concerned as an indication of non-crystallinity [44] . These spherical particles fail to seal septal pores about damage to fungal hyphae. It has been suggested [44] that the Woronin bodies require a dense core in order to withstand the intracellular turgor pressure (which can be as high as 80 MPa [45] ) and hence provide an efficient seal. It is not clear, however, that dense amorphous packing would achieve this any less effectively.
Phloem sieve elements
In plants, transport in the phloem occurs along sieve tubes. The elements of these tubes are connected by sieve plates that contain large pores. When these cells are damaged, it is important that these pores are blocked to prevent leakage. This is achieved through changes to various proteinaceous bodies in the elements [46] . One of these bodies involves P-proteins in crystalline form. In legumes these P-protein crystalloids can undergo a reversible transformation to a dispersed state that can plug the sieve tubes in response to the presence of Ca 2+ [47] .
Disease induced crystallization
For most proteins, crystallization within the cellular is to be avoided, and crystallization is a sign of dysfunction. For example, we know of two diseases that are directly caused by protein crystallization. Firstly, hemoglobin C disease is associated with a mutant form of hemoglobin, in which a glutamate is replaced by lysine. Crystallization of this hemoglobin C can occur in the red blood cells of people who are homozygous for the gene encoding this mutation (CC) or who have a combination of this and the sickle-cell gene (SC). The former case leads to hemoglobin C disease, which is a mild form of anaemia. The physical mechanisms of crystallization of hemoglobin C have been intensively studied [48, 49, 50] . Secondly, mutations in the γ-crystallin proteins can lead to cataracts. In some of these cases, the increase in lens opacity is due to crystallization of the γ-crystallin [51] .
There are then numerous examples where protein crystals have been discovered to be associated with diseases in pathology samples [52] , but often where the role played by the crystals-are they the cause, a harmful side-effect or a harmless byproduct of the disease-and even the protein that has crystallized remain unclear. We have already mentioned the Charcot-Leyden crystals associated with the action of eosinophils. Immunoglobulins, particular the κ light chain, are another set of proteins that have a propensity to form crystals, often in association with cancers [53] .
Crystallization of larger proteinaceous structures
There are also many examples of larger proteinaceous bodies forming (para-) crystalline structures in vivo. For example, in cells containing large numbers of icosahedral viral particles, crystals are frequently seen to occur. The resulting iridescence due to Bragg scattering of visible light lies behind the naming of the iridovirus family [35] . It is not clear whether this behaviour has a functional purpose-perhaps the formation of a crystal maximises the room for more viruses to be produced, or acts like a more primitive means of encapsulation, i.e. the viruses in the centre are protected by those on the outside, or a means for providing a concentrated dose of the virus on transmission.
Crystal-like structures are also seen in rod-shaped viruses, such as tobacco mosaic virus. Other examples include the formation of ribosome crystals in hibernating animals [1] , and crystalline arrays of cellulose fibres.
Two-dimensional crystals are often frequently seen. This can be of membrane proteins, such as cytochrome oxidase [54] , but also of proteins that provide structural rigidity. For example, crystalline arrays of S-layer proteins provide added stability to the cell envelope of many prokaryotes [55] , and the CcmK proteins form hexamers that are the building blocks for the polyhedral shell of bacterial microcompartments, such as the carboxysome [56] .
Conclusion
From even such a short survey -we could have provided many more examples -it is clear that protein crystallization in vivo, while not necessarily ubiquitous, is not nearly as esoteric a phenomenon in biology as one might have thought. In our selection, we have dwelt on those cases that are the most well-characterized, and the function the most clear. However, in a number of instances, particularly those associated with storage, although it is clear why a dense state is favoured, it is less clear why that state needs to be crystalline rather than amorphous. This is highlighted by the example of insulin granules, which are crystalline in humans, but amorphous in guinea pigs. Any selective advantage of the crystalline state is clearly subtle, and it might just be that crystallization is incidental, i.e. neutral evolution has led to two equally viable ways of storing insulin. In such cases, investigating crystallization may yield little fruit for biology, except that the study of crystal contacts may serve to corroborate information obtained from other means regarding the structural consequences of mutations.
By contrast, in cases such as the Woronin bodies, the encapsulated viruses, and the trichocysts, where the mechanical properties of these bodies is vital to their function, understanding crystallization should also yield dividends for understanding essential biological function. Although crystal formation might not be necessary per se to achieve these properties, the intermolecular interactions that induce crystallization also perform important roles in their functions. Biophysical measurements of the mechanical properties of these protein crystals, such as the strength of the HEX-1 and polyhedrin crystal or the forces generated by the expansion of the trichocysts, may also have biological pay-offs.
Probably the biggest difference, between protein crystallization in vitro and in vivo is that the location of the in vivo crystals is vital to their function. In particularly, the cell needs to transport the proteins to their destination without premature crystallization or aggregation. To achieve this, the cell exerts an exquisite control over the interprotein interactions, that would be the envy of any protein crystallographer. In some of the examples, we have seen how this can be achieved through changes in the ionic environment, through proteolysis of precursor proteins, and binding partners that "chaperone" the proteins.
Furthermore, the architecture of the in vivo crystal, both its size and shape, can be vital to its function. This is exemplified by the complexity of the trichocysts. However, the mechanisms by which such control over the crystallization and self-assembly is achieved are still unknown. Much can potentially be learnt from these examples by those who would like to design and build nanostructures. Finally, in vivo crystals are not simply passive. Rather, they can assemble and disassemble in response to environmental signals, they can resist mechanical stresses, and even rapidly undergo massive shape changes. [28] , (c) [57] and (d) [38] .
